<?xml version="1.0" encoding="UTF-8"?>
<cohorts xmlns="http://labkey.org/study/xml">
  <cohort label="Group 1A Placebo: HIV-uninfected participants" enrolled="true" subjectCount="1"/>
  <cohort label="Group 1A: HIV-uninfected participants" enrolled="true" subjectCount="4"/>
  <cohort label="Group 1B Placebo: HIV-uninfected participants" enrolled="true" subjectCount="1"/>
  <cohort label="Group 1B: HIV-uninfected participants" enrolled="true" subjectCount="4"/>
  <cohort label="Group 1C Placebo: HIV-uninfected participants" enrolled="true" subjectCount="1"/>
  <cohort label="Group 1C: HIV-uninfected participants" enrolled="true" subjectCount="4"/>
  <cohort label="Group 2A Placebo: HIV-infected on ART  (&lt;50 cp/ml)" enrolled="true" subjectCount="1"/>
  <cohort label="Group 2A: HIV-infected on ART (&lt;50 cp/ml)" enrolled="true" subjectCount="4"/>
  <cohort label="Group 2B Placebo: HIV-infected on ART  (&lt;50 cp/ml)" enrolled="true" subjectCount="1"/>
  <cohort label="Group 2B: HIV-infected on ART  (&lt;50 cp/ml)" enrolled="true" subjectCount="4"/>
  <cohort label="Group 2C Placebo: HIV-infected on ART  (&lt;50 cp/ml)" enrolled="true" subjectCount="1"/>
  <cohort label="Group 2C: HIV-infected on ART  (&lt;50 cp/ml)" enrolled="true" subjectCount="4"/>
  <cohort label="Group 3A: HIV-Infected off ART (VL 2x10^3 – 1x10^5 cp/ml)" enrolled="true" subjectCount="6"/>
  <cohort label="Group 3B: HIV-Infected off ART (VL 2x10^3 – 1x10^5 cp/ml)" enrolled="true" subjectCount="8"/>
  <cohort label="Group 3C: HIV-Infected off ART (VL 2x10^3 – 1x10^5 cp/ml)" enrolled="true" subjectCount="10"/>
  <cohort label="Group 3D: HIV-Infected off ART (VL 1x10^2 – 2x10^3 cp/ml)" enrolled="true" subjectCount="3"/>
  <cohort label="Group 3E: HIV-Infected off ART (VL 1x10^2 – 2x10^3 cp/ml)" enrolled="true" subjectCount="3"/>
  <cohort label="Group 3F: HIV-Infected off ART (VL 1x10^2 – 2x10^3 cp/ml)" enrolled="true" subjectCount="3"/>
</cohorts>